Latest stories on OPTH
Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy
The Fly56 · neutralproduct/pr
Optimi Health to initiate Phase 2 trial of psilocybin-assisted therapy for MDD
The Fly63 · neutralproduct/pr
Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
GlobeNewswire63 · neutralproduct/pr
Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
Business Insider63 · neutralproduct/pr
Optimi Health to Present at H.C. Wainwright Global Investment Conference
TipRanks56 · neutralgeneral
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Business Insider56 · neutralgeneral
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire56 · neutralgeneral
OPTH Competitors for Optimi Health Corp Stock
Barchart50 · neutralgeneral
OPTH Competitors for Optimi Health Corp Stock
Barchart50 · neutralgeneral
Optimi Health Corp. GAAP EPS of -$0.56, revenue of $239.7M
Seeking Alpha34 · bearishearnings
Optimi Health files to sell 21.94M common shares for holders
The Fly24 · bearishgeneral
Optimi Health Establishes Discretionary Equity Facility
GlobeNewswire28 · bearishgeneral
Optimi Health Establishes Discretionary Equity Facility
Business Insider24 · bearishgeneral
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression | OPTH Stock News
StockTitan63 · neutralproduct/pr
Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research | OPTH Stock News
StockTitan63 · neutralproduct/pr
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial | OPTH Stock News
StockTitan63 · neutralproduct/pr
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
Morningstar59 · neutralproduct/pr
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
PR Newswire63 · neutralproduct/pr
Optimi Health’s Ibogaine Supply Secured as Regulatory Momentum Builds for Psychedelic Therapies
MarketChameleon67 · bullishproduct/pr
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development | OPTH Stock News
StockTitan63 · neutralproduct/pr
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
PR Newswire63 · neutralproduct/pr
Optimi Health Advances Highest-Purity Natural Psilocybin Extract to Date | OPTH Stock News
StockTitan63 · neutralproduct/pr
Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering | OPTH Stock News
StockTitan24 · bearishgeneral